LOUISVILLE, Ken., April 1, 2019 /PRNewswire/ -- US WorldMeds has announced that Sloan Pharma, S.a.r.l., a subsidiary of US WorldMeds Holdings, LLC, has received approval from the U.S. Food and Drug ...
Novartis AG’s irritable bowel drug Zelnorm will come with a new warning that patients could experience severe diarrhea that requires hospital treatment, U.S. regulators said Wednesday. The drug’s new ...
BEDMINSTER, N.J.--(BUSINESS WIRE)--Alfasigma USA, Inc. today announced that ZELNORM™ (tegaserod) is now available in the United States as a prescription pharmaceutical treatment for irritable bowel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results